{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:15:33Z","timestamp":1793315733463,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Organization Department of the CPC Central Committee","award":["Chinese National Thousand Talents Program"],"award-info":[{"award-number":["Chinese National Thousand Talents Program"]}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences (CN)","doi-asserted-by":"publisher","award":["2015RC310003"],"award-info":[{"award-number":["2015RC310003"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["LabEx Immuno-Oncologie"],"award-info":[{"award-number":["LabEx Immuno-Oncologie"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SIRIC Cancer Research and Personalized Medicine","award":["CARPEM"],"award-info":[{"award-number":["CARPEM"]}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["\u00e9quipes labelis\u00e9es"],"award-info":[{"award-number":["\u00e9quipes labelis\u00e9es"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue contre le Cancer","doi-asserted-by":"publisher","award":["\u00e9quipes labelis\u00e9es"],"award-info":[{"award-number":["\u00e9quipes labelis\u00e9es"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00109-016-1401-8","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T20:28:48Z","timestamp":1456864128000},"page":"497-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Therapy-induced microenvironmental changes in cancer"],"prefix":"10.1007","volume":"94","author":[{"given":"Yuting","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"1401_CR1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18:884\u2013901","journal-title":"Dev Cell"},{"key":"1401_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540\u2013550","journal-title":"Nat Rev Cancer"},{"key":"1401_CR3","doi-asserted-by":"crossref","first-page":"18691","DOI":"10.1073\/pnas.1412062112","volume":"111","author":"R Otomo","year":"2014","unstructured":"Otomo R, Otsubo C, Matsushima-Hibiya Y, Miyazaki M, Tashiro F, Ichikawa H, Kohno T, Ochiya T, Yokota J, Nakagama H et al (2014) TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion. Proc Natl Acad Sci U S A 111:18691\u201318696","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1401_CR4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331:1565\u20131570","journal-title":"Science"},{"key":"1401_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15:73\u201386","journal-title":"Nat Rev Immunol"},{"key":"1401_CR6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1349-7006.2012.02293.x","volume":"103","author":"T Shimizu","year":"2012","unstructured":"Shimizu T, Marusawa H, Endo Y, Chiba T (2012) Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci 103:1201\u20131206","journal-title":"Cancer Sci"},{"key":"1401_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz GT, Coukos G (2013) Deciphering and reversing tumor immune suppression. Immunity 39:61\u201373","journal-title":"Immunity"},{"key":"1401_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848\u2013851","journal-title":"Science"},{"key":"1401_CR9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392\u2013401","journal-title":"Nat Rev Cancer"},{"key":"1401_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Arron ST, Hanahan D (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17:135\u2013147","journal-title":"Cancer Cell"},{"key":"1401_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","volume":"26","author":"T Valencia","year":"2014","unstructured":"Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, Duran A, Castilla EA, Metallo CM, Diaz-Meco MT et al (2014) Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell 26:121\u2013135","journal-title":"Cancer Cell"},{"key":"1401_CR12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","volume":"17","author":"SM Weis","year":"2011","unstructured":"Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359\u20131370","journal-title":"Nat Med"},{"key":"1401_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14:159\u2013172","journal-title":"Nat Rev Cancer"},{"key":"1401_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smim.2010.03.001","volume":"22","author":"Y Ma","year":"2010","unstructured":"Ma Y, Kepp O, Ghiringhelli F, Apetoh L, Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM et al (2010) Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin Immunol 22:113\u2013124","journal-title":"Semin Immunol"},{"key":"1401_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trecan.2015.07.008","volume":"1","author":"TR Medler","year":"2015","unstructured":"Medler TR, Cotechini T, Coussens LM (2015) Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance. Trend Canc 1:66\u201375","journal-title":"Trend Canc"},{"key":"1401_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51\u201372","journal-title":"Annu Rev Immunol"},{"key":"1401_CR17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661\u2013672","journal-title":"Nat Rev Microbiol"},{"key":"1401_CR18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350:1084\u20131089","journal-title":"Science"},{"key":"1401_CR19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:1079\u20131084","journal-title":"Science"},{"key":"1401_CR20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ et al (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342:971\u2013976","journal-title":"Science"},{"key":"1401_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/2326-6066.CIR-14-0225","volume":"3","author":"RS Goldszmid","year":"2015","unstructured":"Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G (2015) Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res 3:103\u2013109","journal-title":"Cancer Immunol Res"},{"key":"1401_CR22","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","volume":"24","author":"T Kuilman","year":"2010","unstructured":"Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24:2463\u20132479","journal-title":"Genes Dev"},{"key":"1401_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10:51\u201357","journal-title":"Nat Rev Cancer"},{"key":"1401_CR24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M et al (2005) Tumour biology: senescence in premalignant tumours. Nature 436:642","journal-title":"Nature"},{"key":"1401_CR25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725\u2013730","journal-title":"Nature"},{"key":"1401_CR26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O\u2019Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N et al (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133:1006\u20131018","journal-title":"Cell"},{"key":"1401_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M et al (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15:978\u2013990","journal-title":"Nat Cell Biol"},{"key":"1401_CR28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/mt.2012.19","volume":"20","author":"Y Meng","year":"2012","unstructured":"Meng Y, Efimova EV, Hamzeh KW, Darga TE, Mauceri HJ, Fu YX, Kron SJ, Weichselbaum RR (2012) Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. Molecul Ther J Am Soc Gene Ther 20:1046\u20131055","journal-title":"Molecul Ther J Am Soc Gene Ther"},{"key":"1401_CR29","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/0008-5472.CAN-06-3452","volume":"67","author":"D Liu","year":"2007","unstructured":"Liu D, Hornsby PJ (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67:3117\u20133126","journal-title":"Cancer Res"},{"key":"1401_CR30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019\u20131031","journal-title":"Cell"},{"key":"1401_CR31","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1172\/JCI72619","volume":"124","author":"M Rielland","year":"2014","unstructured":"Rielland M, Cantor DJ, Graveline R, Hajdu C, Mara L, Diaz Bde D, Miller G, David G (2014) Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. J Clin Invest 124:2125\u20132135","journal-title":"J Clin Invest"},{"key":"1401_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M et al (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499:97\u2013101","journal-title":"Nature"},{"key":"1401_CR33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccr.2013.06.005","volume":"24","author":"A Pribluda","year":"2013","unstructured":"Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H et al (2013) A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 24:242\u2013256","journal-title":"Cancer Cell"},{"key":"1401_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang M, Kaufman RJ (2014) The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer 14:581\u2013597","journal-title":"Nat Rev Cancer"},{"key":"1401_CR35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ncb3184","volume":"17","author":"C Hetz","year":"2015","unstructured":"Hetz C, Chevet E, Oakes SA (2015) Proteostasis control by the unfolded protein response. Nat Cell Biol 17:829\u2013838","journal-title":"Nat Cell Biol"},{"key":"1401_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","volume":"25","author":"HJ Clarke","year":"2014","unstructured":"Clarke HJ, Chambers JE, Liniker E, Marciniak SJ (2014) Endoplasmic reticulum stress in malignancy. Cancer Cell 25:563\u2013573","journal-title":"Cancer Cell"},{"key":"1401_CR37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(03)00029-1","volume":"38","author":"M Shuda","year":"2003","unstructured":"Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O et al (2003) Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38:605\u2013614","journal-title":"J Hepatol"},{"key":"1401_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.urology.2009.05.007","volume":"75","author":"W Fu","year":"2010","unstructured":"Fu W, Wu X, Li J, Mo Z, Yang Z, Huang W, Ding Q (2010) Upregulation of GRP78 in renal cell carcinoma and its significance. Urology 75:603\u2013607","journal-title":"Urology"},{"key":"1401_CR39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cca.2005.07.016","volume":"364","author":"X Xing","year":"2006","unstructured":"Xing X, Lai M, Wang Y, Xu E, Huang Q (2006) Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta Int J Clin Chem 364:308\u2013315","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"1401_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2004.12.011","volume":"49","author":"H Uramoto","year":"2005","unstructured":"Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Yoshimastu T, Morita M, Yasumoto K (2005) Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung Cancer 49:55\u201362","journal-title":"Lung Cancer"},{"key":"1401_CR41","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-08-2870","volume":"15","author":"JA Schardt","year":"2009","unstructured":"Schardt JA, Weber D, Eyholzer M, Mueller BU, Pabst T (2009) Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Clin Canc Re Offic J Am Assoc Canc Res 15:3834\u20133841","journal-title":"Clin Canc Re Offic J Am Assoc Canc Res"},{"key":"1401_CR42","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/onc.2010.153","volume":"29","author":"E Bobrovnikova-Marjon","year":"2010","unstructured":"Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D, Diehl JA (2010) PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 29:3881\u20133895","journal-title":"Oncogene"},{"key":"1401_CR43","doi-asserted-by":"crossref","unstructured":"Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D et al (2006) Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 4:e374. doi: 10.1371\/journal.pbio.0040374","DOI":"10.1371\/journal.pbio.0040374"},{"key":"1401_CR44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-pathol-020712-163918","volume":"8","author":"L Murrow","year":"2013","unstructured":"Murrow L, Debnath J (2013) Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu Rev Pathol 8:105\u2013137","journal-title":"Annu Rev Pathol"},{"key":"1401_CR45","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","volume":"112","author":"X Qu","year":"2003","unstructured":"Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y et al (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809\u20131820","journal-title":"J Clin Invest"},{"key":"1401_CR46","doi-asserted-by":"crossref","first-page":"18573","DOI":"10.1074\/jbc.M701194200","volume":"282","author":"G Marino","year":"2007","unstructured":"Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez-Otin C (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C\/autophagin-3. J Biol Chem 282:18573\u201318583","journal-title":"J Biol Chem"},{"key":"1401_CR47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C et al (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137:1062\u20131075","journal-title":"Cell"},{"key":"1401_CR48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1101\/gad.1545107","volume":"21","author":"R Mathew","year":"2007","unstructured":"Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367\u20131381","journal-title":"Genes Dev"},{"key":"1401_CR49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","volume":"8","author":"F Janku","year":"2011","unstructured":"Janku F, McConkey DJ, Hong DS, Kurzrock R (2011) Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8:528\u2013539","journal-title":"Nat Rev Clin Oncol"},{"key":"1401_CR50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI40027","volume":"120","author":"KM Rouschop","year":"2010","unstructured":"Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW et al (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 120:127\u2013141","journal-title":"J Clin Invest"},{"key":"1401_CR51","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","volume":"72","author":"YL Hu","year":"2012","unstructured":"Hu YL, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72:1773\u20131783","journal-title":"Cancer Res"},{"key":"1401_CR52","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","volume":"72","author":"JW Wojtkowiak","year":"2012","unstructured":"Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, Gillies RJ (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938\u20133947","journal-title":"Cancer Res"},{"key":"1401_CR53","doi-asserted-by":"crossref","unstructured":"Fang H, Liu A, Dahmen U, Dirsch O (2013) Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. Cell Death Dis 4:e694. doi: 10.1038\/cddis.2013.225","DOI":"10.1038\/cddis.2013.225"},{"key":"1401_CR54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X et al (2015) Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525:389\u2013393","journal-title":"Nature"},{"key":"1401_CR55","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cas.12484","volume":"105","author":"H Nakajima","year":"2014","unstructured":"Nakajima H, Kunimoto H (2014) TET2 as an epigenetic master regulator for normal and malignant hematopoiesis. Cancer Sci 105:1093\u20131099","journal-title":"Cancer Sci"},{"key":"1401_CR56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","volume":"13","author":"SJ Song","year":"2013","unstructured":"Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE et al (2013) The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13:87\u2013101","journal-title":"Cell Stem Cell"},{"key":"1401_CR57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883\u2013899","journal-title":"Cell"},{"key":"1401_CR58","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI19757","volume":"112","author":"LJ Hofseth","year":"2003","unstructured":"Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, Kartalou M, Hussain SP, Roth RB, Zhou X, Mechanic LE et al (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest 112:1887\u20131894","journal-title":"J Clin Invest"},{"key":"1401_CR59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"1401_CR60","doi-asserted-by":"crossref","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immun Res 2014:149185. doi: 10.1155\/2014\/149185","DOI":"10.1155\/2014\/149185"},{"key":"1401_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306","journal-title":"Nat Rev Cancer"},{"key":"1401_CR62","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI31184","volume":"117","author":"JF Grosso","year":"2007","unstructured":"Grosso JF, Kelleher CC, Harris TJ, Maris CH, Hipkiss EL, De Marzo A, Anders R, Netto G, Getnet D, Bruno TC et al (2007) LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 117:3383\u20133392","journal-title":"J Clin Invest"},{"key":"1401_CR63","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/0008-5472.CAN-11-2637","volume":"72","author":"J Fourcade","year":"2012","unstructured":"Fourcade J, Sun Z, Pagliano O, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Olive D, Kuchroo V, Zarour HM (2012) CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res 72:887\u2013896","journal-title":"Cancer Res"},{"key":"1401_CR64","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC (2010) Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 207:2187\u20132194","journal-title":"J Exp Med"},{"key":"1401_CR65","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1158\/0008-5472.CAN-10-2028","volume":"70","author":"A Anichini","year":"2010","unstructured":"Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M et al (2010) Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma. Cancer Res 70:8378\u20138387","journal-title":"Cancer Res"},{"key":"1401_CR66","first-page":"1165","volume":"118","author":"C Liu","year":"2008","unstructured":"Liu C, Lou Y, Lizee G, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG et al (2008) Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 118:1165\u20131175","journal-title":"J Clin Invest"},{"key":"1401_CR67","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","volume":"19","author":"JB Guillerme","year":"2013","unstructured":"Guillerme JB, Boisgerault N, Roulois D, Menager J, Combredet C, Tangy F, Fonteneau JF, Gregoire M (2013) Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells. Clin Canc Re Offic J Am Assoc Canc Res 19:1147\u20131158","journal-title":"Clin Canc Re Offic J Am Assoc Canc Res"},{"key":"1401_CR68","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood-2012-06-435941","volume":"120","author":"J Tel","year":"2012","unstructured":"Tel J, Smits EL, Anguille S, Joshi RN, Figdor CG, de Vries IJ (2012) Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood 120:3936\u20133944","journal-title":"Blood"},{"key":"1401_CR69","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/jid.2014.29","volume":"134","author":"C Camisaschi","year":"2014","unstructured":"Camisaschi C, De Filippo A, Beretta V, Vergani B, Villa A, Vergani E, Santinami M, Cabras AD, Arienti F, Triebel F et al (2014) Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3. J Invest Dermatol 134:1893\u20131902","journal-title":"J Invest Dermatol"},{"key":"1401_CR70","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","volume":"124","author":"EB Eruslanov","year":"2014","unstructured":"Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW et al (2014) Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 124:5466\u20135480","journal-title":"J Clin Invest"},{"key":"1401_CR71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell 16:183\u2013194","journal-title":"Cancer Cell"},{"key":"1401_CR72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.it.2007.05.008","volume":"28","author":"M Terabe","year":"2007","unstructured":"Terabe M, Berzofsky JA (2007) NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol 28:491\u2013496","journal-title":"Trends Immunol"},{"key":"1401_CR73","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2174\/092986710793176339","volume":"17","author":"L Bertazza","year":"2010","unstructured":"Bertazza L, Mocellin S (2010) The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem 17:3337\u20133352","journal-title":"Curr Med Chem"},{"key":"1401_CR74","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.5RU0714-360RR","volume":"97","author":"M Fabbi","year":"2015","unstructured":"Fabbi M, Carbotti G, Ferrini S (2015) Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J Leukoc Biol 97:665\u2013675","journal-title":"J Leukoc Biol"},{"key":"1401_CR75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2012.11.002","volume":"149","author":"NY Hemdan","year":"2013","unstructured":"Hemdan NY (2013) Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells. Immunol Lett 149:123\u2013133","journal-title":"Immunol Lett"},{"key":"1401_CR76","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","volume":"78","author":"S Mocellin","year":"2005","unstructured":"Mocellin S, Marincola FM, Young HA (2005) Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78:1043\u20131051","journal-title":"J Leukoc Biol"},{"key":"1401_CR77","first-page":"127","volume":"4","author":"JA Tickner","year":"2014","unstructured":"Tickner JA, Urquhart AJ, Stephenson SA, Richard DJ, O\u2019Byrne KJ (2014) Functions and therapeutic roles of exosomes in cancer. Frontier Oncol 4:127","journal-title":"Frontier Oncol"},{"key":"1401_CR78","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","volume":"91","author":"C Kahlert","year":"2013","unstructured":"Kahlert C, Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91:431\u2013437","journal-title":"J Mol Med (Berl)"},{"key":"1401_CR79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","volume":"7","author":"J Wolfers","year":"2001","unstructured":"Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T et al (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297\u2013303","journal-title":"Nat Med"},{"key":"1401_CR80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","volume":"360","author":"F Andre","year":"2002","unstructured":"Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T et al (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360:295\u2013305","journal-title":"Lancet"},{"key":"1401_CR81","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174","journal-title":"Nat Rev Immunol"},{"key":"1401_CR82","first-page":"190","volume":"4","author":"DO Adeegbe","year":"2013","unstructured":"Adeegbe DO, Nishikawa H (2013) Natural and induced T regulatory cells in cancer. Frontier Immunol 4:190","journal-title":"Frontier Immunol"},{"key":"1401_CR83","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","volume":"13","author":"RB Holmgaard","year":"2015","unstructured":"Holmgaard RB, Zamarin D, Li Y, Gasmi B, Munn DH, Allison JP, Merghoub T, Wolchok JD (2015) Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner. Cell Rep 13:412\u2013424","journal-title":"Cell Rep"},{"key":"1401_CR84","doi-asserted-by":"crossref","unstructured":"Vacchelli E, Aranda F, Eggermont A, Sautes-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunol 3:e957994. doi: 10.4161\/21624011.2014.957994","DOI":"10.4161\/21624011.2014.957994"},{"key":"1401_CR85","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","volume":"13","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13:842\u2013857","journal-title":"Nat Rev Cancer"},{"key":"1401_CR86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188:21\u201328","journal-title":"J Immunol"},{"key":"1401_CR87","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte V, Zanovello P (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5:641\u2013654","journal-title":"Nat Rev Immunol"},{"key":"1401_CR88","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/icb.2014.67","volume":"92","author":"V Bronte","year":"2014","unstructured":"Bronte V (2014) Tumor cells hijack macrophages via lactic acid. Immunol Cell Biol 92:647\u2013649","journal-title":"Immunol Cell Biol"},{"key":"1401_CR89","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup M, Novitskiy S, Moses HL (2013) The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer 13:788\u2013799","journal-title":"Nat Rev Cancer"},{"key":"1401_CR90","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA (2014) Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer 14:611\u2013622","journal-title":"Nat Rev Cancer"},{"key":"1401_CR91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","volume":"150","author":"H Gao","year":"2012","unstructured":"Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG (2012) The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150:764\u2013779","journal-title":"Cell"},{"key":"1401_CR92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrc2621","volume":"9","author":"B Psaila","year":"2009","unstructured":"Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285\u2013293","journal-title":"Nat Rev Cancer"},{"key":"1401_CR93","doi-asserted-by":"crossref","unstructured":"Vacchelli E, Vitale I, Tartour E, Eggermont A, Sautes-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L (2013) Trial watch: anticancer radioimmunotherapy. OncoImmunol 2:e25595. doi: 10.4161\/onci.25595","DOI":"10.4161\/onci.25595"},{"key":"1401_CR94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","volume":"39","author":"L Zitvogel","year":"2013","unstructured":"Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G (2013) Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39:74\u201388","journal-title":"Immunity"},{"key":"1401_CR95","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54\u201361","journal-title":"Nat Med"},{"key":"1401_CR96","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","volume":"28","author":"T Panaretakis","year":"2009","unstructured":"Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P et al (2009) Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 28:578\u2013590","journal-title":"EMBO J"},{"key":"1401_CR97","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15:1170\u20131178","journal-title":"Nat Med"},{"key":"1401_CR98","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050\u20131059","journal-title":"Nat Med"},{"key":"1401_CR99","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remedios C et al (2014) Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med 20:1301\u20131309","journal-title":"Nat Med"},{"key":"1401_CR100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2012.03.008","volume":"36","author":"S Ahrens","year":"2012","unstructured":"Ahrens S, Zelenay S, Sancho D, Hanc P, Kjaer S, Feest C, Fletcher G, Durkin C, Postigo A, Skehel M et al (2012) F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 36:635\u2013645","journal-title":"Immunity"},{"key":"1401_CR101","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","volume":"202","author":"N Casares","year":"2005","unstructured":"Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M et al (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202:1691\u20131701","journal-title":"J Exp Med"},{"key":"1401_CR102","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","volume":"38","author":"Y Ma","year":"2013","unstructured":"Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K et al (2013) Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 38:729\u2013741","journal-title":"Immunity"},{"key":"1401_CR103","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","volume":"31","author":"AD Garg","year":"2012","unstructured":"Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ et al (2012) A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 31:1062\u20131079","journal-title":"EMBO J"},{"key":"1401_CR104","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","volume":"21","author":"I Martins","year":"2014","unstructured":"Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Metivier D, Galluzzi L, Perfettini JL et al (2014) Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 21:79\u201391","journal-title":"Cell Death Differ"},{"key":"1401_CR105","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nm1679","volume":"13","author":"PM Rawson","year":"2007","unstructured":"Rawson PM, Molette C, Videtta M, Altieri L, Franceschini D, Donato T, Finocchi L, Propato A, Paroli M, Meloni F et al (2007) Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 13:1431\u20131439","journal-title":"Nat Med"},{"key":"1401_CR106","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/0008-5472.CAN-07-0562","volume":"68","author":"A Apel","year":"2008","unstructured":"Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A (2008) Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 68:1485\u20131494","journal-title":"Cancer Res"},{"key":"1401_CR107","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI28833","volume":"117","author":"RK Amaravadi","year":"2007","unstructured":"Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326\u2013336","journal-title":"J Clin Invest"},{"key":"1401_CR108","doi-asserted-by":"crossref","unstructured":"Kuwahara Y, Oikawa T, Ochiai Y, Roudkenar MH, Fukumoto M, Shimura T, Ohtake Y, Ohkubo Y, Mori S, Uchiyama Y (2011) Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis 2:e177. doi: 10.1038\/cddis.2011.56","DOI":"10.1038\/cddis.2011.56"},{"key":"1401_CR109","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccr.2008.06.004","volume":"14","author":"S Turcotte","year":"2008","unstructured":"Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ (2008) A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 14:90\u2013102","journal-title":"Cancer Cell"},{"key":"1401_CR110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/cdd.2014.143","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu Y, Levine B (2015) Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ 22:367\u2013376","journal-title":"Cell Death Differ"},{"key":"1401_CR111","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","volume":"334","author":"M Michaud","year":"2011","unstructured":"Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G et al (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334:1573\u20131577","journal-title":"Science"},{"key":"1401_CR112","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4161\/auto.25873","volume":"9","author":"Y Wang","year":"2013","unstructured":"Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G (2013) Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy 9:1624\u20131625","journal-title":"Autophagy"},{"key":"1401_CR113","doi-asserted-by":"crossref","unstructured":"Bonnefoy N, Bastid J, Alberici G, Bensussan A, Eliaou JF (2015) CD39: a complementary target to immune checkpoints to counteract tumor-mediated immunosuppression. OncoImmunol 4:e1003015. doi: 10.1080\/2162402X.2014.1003015","DOI":"10.1080\/2162402X.2014.1003015"},{"key":"1401_CR114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209\u2013223","journal-title":"Immunity"},{"key":"1401_CR115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/0008-5472.CAN-09-1890","volume":"70","author":"R Conforti","year":"2010","unstructured":"Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, Ryffel B, Ferrantini M, Uppaluri R, Schreiber R et al (2010) Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer Res 70:490\u2013500","journal-title":"Cancer Res"},{"key":"1401_CR116","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reise Sousa C, Green DR, Oberst A, Albert ML (2015) RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science 350:328\u2013334","journal-title":"Science"},{"key":"1401_CR117","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1158\/2326-6066.CIR-14-0219","volume":"3","author":"R Takemura","year":"2015","unstructured":"Takemura R, Takaki H, Okada S, Shime H, Akazawa T, Oshiumi H, Matsumoto M, Teshima T, Seya T (2015) PolyI:C-induced, TLR3\/RIP3-dependent necroptosis backs up immune effector-mediated tumor elimination in vivo. Cancer Immunol Res 3:902\u2013914","journal-title":"Cancer Immunol Res"},{"key":"1401_CR118","author":"H Yang","year":"2016","unstructured":"Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A et al (2016) Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. OncoImmunol. doi: 10.1080\/2162402X.2016.1149673","journal-title":"OncoImmunol"},{"key":"1401_CR119","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1101\/gad.17276711","volume":"25","author":"Y Chien","year":"2011","unstructured":"Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS et al (2011) Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev 25:2125\u20132136","journal-title":"Genes Dev"},{"key":"1401_CR120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso A, Revandkar A, Di Mitri D, Guccini I, Proietti M, Sarti M, Pinton S, Zhang J, Kalathur M, Civenni G et al (2014) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep 9:75\u201389","journal-title":"Cell Rep"},{"key":"1401_CR121","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1080\/15548627.2015.1082022","volume":"11","author":"S Ladoire","year":"2015","unstructured":"Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L et al (2015) Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy 11:1878\u20131890","journal-title":"Autophagy"},{"issue":"Suppl 5","key":"1401_CR122","doi-asserted-by":"crossref","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J Naurois de","year":"2010","unstructured":"de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annal Oncol Offic J Eur Soc Med Oncol \/ ESMO 21(Suppl 5):v252\u2013v256","journal-title":"Annal Oncol Offic J Eur Soc Med Oncol \/ ESMO"},{"key":"1401_CR123","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I et al (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383\u20135391","journal-title":"Cancer Res"},{"key":"1401_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molonc.2011.11.005","volume":"6","author":"E Proietti","year":"2012","unstructured":"Proietti E, Moschella F, Capone I, Belardelli F (2012) Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy. Mol Oncol 6:1\u201314","journal-title":"Mol Oncol"},{"key":"1401_CR125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2012.362","volume":"107","author":"MJ McCoy","year":"2012","unstructured":"McCoy MJ, Lake RA, van der Most RG, Dick IM, Nowak AK (2012) Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies. Br J Cancer 107:1107\u20131115","journal-title":"Br J Cancer"},{"key":"1401_CR126","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4161\/auto.7.9.15886","volume":"7","author":"M Mortensen","year":"2011","unstructured":"Mortensen M, Watson AS, Simon AK (2011) Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy 7:1069\u20131070","journal-title":"Autophagy"},{"key":"1401_CR127","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/cdd.2011.78","volume":"19","author":"JR Kovacs","year":"2012","unstructured":"Kovacs JR, Li C, Yang Q, Li G, Garcia IG, Ju S, Roodman DG, Windle JJ, Zhang X, Lu B (2012) Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ 19:144\u2013152","journal-title":"Cell Death Differ"},{"key":"1401_CR128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20061303","volume":"204","author":"HH Pua","year":"2007","unstructured":"Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW (2007) A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 204:25\u201331","journal-title":"J Exp Med"},{"key":"1401_CR129","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2011-08-372383","volume":"119","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Morgan MJ, Chen K, Choksi S, Liu ZG (2012) Induction of autophagy is essential for monocyte-macrophage differentiation. Blood 119:2895\u20132905","journal-title":"Blood"},{"key":"1401_CR130","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2011-11-392167","volume":"119","author":"A Jacquel","year":"2012","unstructured":"Jacquel A, Obba S, Boyer L, Dufies M, Robert G, Gounon P, Lemichez E, Luciano F, Solary E, Auberger P (2012) Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions. Blood 119:4527\u20134531","journal-title":"Blood"},{"key":"1401_CR131","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.4161\/cc.26298","volume":"12","author":"V Tuloup-Minguez","year":"2013","unstructured":"Tuloup-Minguez V, Hamai A, Greffard A, Nicolas V, Codogno P, Botti J (2013) Autophagy modulates cell migration and beta1 integrin membrane recycling. Cell Cycle 12:3317\u20133328","journal-title":"Cell Cycle"},{"key":"1401_CR132","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2013.07.017","volume":"39","author":"Y Ma","year":"2013","unstructured":"Ma Y, Galluzzi L, Zitvogel L, Kroemer G (2013) Autophagy and cellular immune responses. Immunity 39:211\u2013227","journal-title":"Immunity"},{"key":"1401_CR133","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni.3015","volume":"15","author":"X Wang","year":"2014","unstructured":"Wang X, Jiang W, Yan Y, Gong T, Han J, Tian Z, Zhou R (2014) RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol 15:1126\u20131133","journal-title":"Nat Immunol"},{"key":"1401_CR134","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K et al (2015) ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161:1527\u20131538","journal-title":"Cell"},{"key":"1401_CR135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/0008-5472.CAN-13-1265","volume":"74","author":"Y Ma","year":"2014","unstructured":"Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O et al (2014) CCL2\/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Res 74:436\u2013445","journal-title":"Cancer Res"},{"key":"1401_CR136","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20100269","volume":"208","author":"Y Ma","year":"2011","unstructured":"Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N et al (2011) Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 208:491\u2013503","journal-title":"J Exp Med"},{"key":"1401_CR137","doi-asserted-by":"crossref","unstructured":"Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M et al (2015) Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science 350:972\u2013978. doi: 10.1126\/science.aad0779","DOI":"10.1126\/science.aad0779"},{"key":"1401_CR138","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","volume":"38","author":"AT Wild","year":"2015","unstructured":"Wild AT, Ye X, Ellsworth SG, Smith JA, Narang AK, Garg T, Campian J, Laheru DA, Zheng L, Wolfgang CL et al (2015) The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma. Am J Clin Oncol 38:259\u2013265","journal-title":"Am J Clin Oncol"},{"key":"1401_CR139","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1158\/1078-0432.CCR-13-0900","volume":"19","author":"PJ Schuler","year":"2013","unstructured":"Schuler PJ, Harasymczuk M, Schilling B, Saze Z, Strauss L, Lang S, Johnson JT, Whiteside TL (2013) Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer. Clin Canc Re Offic J Am Assoc Canc Res 19:6585\u20136596","journal-title":"Clin Canc Re Offic J Am Assoc Canc Res"},{"key":"1401_CR140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, Li XD, Mauceri H, Beckett M, Darga T et al (2014) STING-dependent cytosolic DNA sensing promotes radiation-induced type i interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41:843\u2013852","journal-title":"Immunity"},{"key":"1401_CR141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","volume":"39","author":"J Galon","year":"2013","unstructured":"Galon J, Angell HK, Bedognetti D, Marincola FM (2013) The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 39:11\u201326","journal-title":"Immunity"},{"key":"1401_CR142","doi-asserted-by":"crossref","unstructured":"Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M, Kroemer G (2015) Cancer and the gut microbiota: an unexpected link. Sci Trans Med 7:271ps271. doi: 10.1126\/scitranslmed.3010473","DOI":"10.1126\/scitranslmed.3010473"},{"key":"1401_CR143","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2014.01.001","volume":"146","author":"MT Abreu","year":"2014","unstructured":"Abreu MT, Peek RM Jr (2014) Gastrointestinal malignancy and the microbiome. Gastroenterology 146:1534\u20131546, e1533","journal-title":"Gastroenterology"},{"key":"1401_CR144","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","volume":"15","author":"CL Sears","year":"2014","unstructured":"Sears CL, Garrett WS (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe 15:317\u2013328","journal-title":"Cell Host Microbe"},{"key":"1401_CR145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS (2015) Cancer and the microbiota. Science 348:80\u201386","journal-title":"Science"},{"key":"1401_CR146","first-page":"5","volume":"6","author":"TL Gur","year":"2015","unstructured":"Gur TL, Worly BL, Bailey MT (2015) Stress and the commensal microbiota: importance in parturition and infant neurodevelopment. Frontier Psychiatr 6:5","journal-title":"Frontier Psychiatr"},{"key":"1401_CR147","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.20131587","volume":"211","author":"G Bongers","year":"2014","unstructured":"Bongers G, Pacer ME, Geraldino TH, Chen L, He Z, Hashimoto D, Furtado GC, Ochando J, Kelley KA, Clemente JC et al (2014) Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med 211:457\u2013472","journal-title":"J Exp Med"},{"key":"1401_CR148","doi-asserted-by":"crossref","first-page":"18321","DOI":"10.1073\/pnas.1406199111","volume":"111","author":"CM Dejea","year":"2014","unstructured":"Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M et al (2014) Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A 111:18321\u201318326","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1401_CR149","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18632\/oncoscience.145","volume":"2","author":"MR Rutkowski","year":"2015","unstructured":"Rutkowski MR, Conejo-Garcia JR (2015) Size does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity. Oncosci 2:239\u2013246","journal-title":"Oncosci"},{"key":"1401_CR150","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1158\/0008-5472.CAN-05-4592","volume":"66","author":"A Rossini","year":"2006","unstructured":"Rossini A, Rumio C, Sfondrini L, Tagliabue E, Morelli D, Miceli R, Mariani L, Palazzo M, Menard S, Balsari A (2006) Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res 66:6219\u20136224","journal-title":"Cancer Res"},{"key":"1401_CR151","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10:324\u2013335","journal-title":"Cell Host Microbe"},{"key":"1401_CR152","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","volume":"291","author":"CM Velicer","year":"2004","unstructured":"Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH (2004) Antibiotic use in relation to the risk of breast cancer. JAMA 291:827\u2013835","journal-title":"JAMA"},{"key":"1401_CR153","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342:967\u2013970","journal-title":"Science"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1401-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1401-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:27:51Z","timestamp":1558571271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":153,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1401-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}